Hypertension in adults: diagnosis and management
KEYWORDS: blood, pressure, blood pressure, people, treatment, hypertension, committee, evidence, recommendations, cardiovascular, recommendation, disease, guideline, step, diabetes

hypertension. [2019] 1.4.35 Offer a calcium-channel blocker (CCB) to adults starting step 1 antihypertensive treatment who: • are aged 55 or over and do not have type 2 diabetes or • are of Black African or African–Caribbean family origin and do not have type 2 diabetes (of any age). [2019] 1.4.36 If a CCB is not tolerated, for example because of oedema, offer a thiazide-like diuretic to treat hypertension. [2019] 1.4.37 If there is evidence of heart failure, offer a thiazide-like diuretic and follow NICE's guideline on chronic heart failure. [2019] 1.4.38 If starting or changing diuretic treatment for hypertension, offer a thiazide-like diuretic, such as indapamide in preference to a conventional thiazide diuretic such as bendroflumethiazide or hydrochlorothiazide. [2019] 1.4.39 For adults with hypertension already having treatment with bendroflumethiazide or hydrochlorothiazide, who have stable, well-controlled blood pressure, continue with their current treatment. [2019] For a short explanation of why the committee made the 2019 recommendations and how they might affect practice, see the rationale and impact section on step 1 treatment. Full details of the evidence and the committee's discussion are in evidence review E: step 1 treatment. Step 2 treatment 1.4.40 Before considering next step treatment for hypertension
